D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUOT
1201
DELISTED
Quotient Technology Inc
QUOT
| $10.8M | 0.01% |
663,267
+142,687
| +27% | +$1.76M |
|
1202
Fossil Group
FOSL
$249M
| $10.8M | 0.01% |
873,101
-250,034
| -22% | -$3.5M |
|
1203
Owens Corning
OC
$11.6B
| $10.8M | 0.01% |
117,457
-80,511
| -41% | -$6.75M |
|
1204
PUT
RTX Corp
RTX
$294B
| $10.8M | 0.01% |
139,700
-136,702
| -49% | -$9.98M |
|
|
HOUS
1205
DELISTED
Anywhere Real Estate
HOUS
| $10.8M | 0.01% |
713,419
-620,282
| -47% | -$9.86M |
|
1206
CALL
Chegg
CHGG
$110M
| $10.8M | 0.01% |
126,000
+44,900
| +55% | +$4.28M |
|
1207
Alpha and Omega Semiconductor
AOSL
$922M
| $10.8M | 0.01% |
329,513
-30,721
| -9% | -$1.01M |
|
1208
Sysco
SYY
$40.2B
| $10.7M | 0.01% |
+136,179
| New | +$10.6M |
|
1209
Ocular Therapeutix
OCUL
$1.89B
| $10.7M | 0.01% |
652,128
-397,618
| -38% | -$7.66M |
|
|
PCPC
1210
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $10.7M | 0.01% |
+450,000
| New | +$11.2M |
|
1211
Sonic Automotive
SAH
$3.25B
| $10.7M | 0.01% |
215,386
+195,896
| +1,005% | +$9.09M |
|
1212
CALL
American Tower
AMT
$77.7B
| $10.7M | 0.01% |
44,600
-26,400
| -37% | -$5.88M |
|
1213
CALL
FirstEnergy
FE
$28.5B
| $10.7M | 0.01% |
307,200
+20,800
| +7% | +$679K |
|
1214
National Vision
EYE
$1.66B
| $10.6M | 0.01% |
242,943
+50,232
| +26% | +$2.39M |
|
1215
Pitney Bowes
PBI
$2.46B
| $10.6M | 0.01% |
1,291,812
-1,634,213
| -56% | -$14M |
|
1216
Norfolk Southern
NSC
$77.1B
| $10.6M | 0.01% |
39,563
-145,380
| -79% | -$36.8M |
|
1217
KT
KT
$8.92B
| $10.6M | 0.01% |
853,800
+379,955
| +80% | +$4.31M |
|
|
1218
PUT
American Tower
AMT
$77.7B
| $10.6M | 0.01% |
44,400
-66,400
| -60% | -$14.8M |
|
1219
Accuray
ARAY
$26.8M
| $10.5M | 0.01% |
2,128,272
-581,403
| -21% | -$3M |
|
|
GRP.U
1220
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $10.5M | 0.01% |
172,568
-3,700
| -2% | -$221K |
|
1221
PUT
Valero Energy
VLO
$90.5B
| $10.5M | 0.01% |
146,100
-196,900
| -57% | -$13.4M |
|
|
CONX
1222
DELISTED
CONX Corp. Class A Common Stock
CONX
| $10.4M | 0.01% |
+1,046,915
| New | +$10.8M |
|
1223
PUT
lululemon athletica
LULU
$13.4B
| $10.4M | 0.01% |
34,000
+18,800
| +124% | +$6.17M |
|
1224
PUT
Northrop Grumman
NOC
$77.8B
| $10.4M | 0.01% |
32,200
-15,000
| -32% | -$4.52M |
|
1225
Healthcare Services Group
HCSG
$1.58B
| $10.4M | 0.01% |
371,693
-204,536
| -35% | -$6.17M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.